Effectiveness of paliperidone palmitate one-month long-acting injection in obese vs. non-obese patients

被引：0
|
作者：
Dorflinger, Charles [1 ]
LeHew, Colleen [1 ]
Carey, Heather [1 ]
Roche-Desilets, Jennifer [1 ]
Burant, Christopher J. [2 ,3 ]
机构：
[1] VA Northeast Ohio Healthcare Syst, Pharm Dept, 10701 East Blvd, Cleveland, OH 44106 USA
[2] VA Northeast Ohio Healthcare Syst, Geriatr Res Educ & Clin Ctr, 10701 East Blvd, Cleveland, OH 44106 USA
[3] Case Western Reserve Univ, Frances Payne Bolton Sch Nursing, 10900 Euclid Ave, Cleveland, OH 44106 USA
来源：
COMPREHENSIVE PSYCHIATRY | 2021年 / 111卷
关键词：
MEDICATION ADHERENCE; SCHIZOPHRENIA; PREVALENCE;
D O I：
10.1016/j.comppsych.2021.152269
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
[No abstract available]
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Airway events in obese vs. non-obese elective surgical patients: a cross-sectional observational study
    Shaw, M.
    Waiting, J.
    Barraclough, L.
    Ting, K.
    Jeans, J.
    Black, B.
    ANAESTHESIA, 2021, 76 (12) : 1585 - 1592
  • [42] Healthcare resource use of paliperidone palmitate 3-month injection vs. paliperidone palmitate 1-month injection: An analysis of phase III clinical trial hospital data
    Woodruff, K.
    Chirila, C.
    Zheng, Q.
    Van Impe, K.
    Nuamah, I.
    EUROPEAN PSYCHIATRY, 2016, 33 : S265 - S266
  • [43] EVALUATION OF PALIPERIDONE PALMITATE LONG-ACTING INJECTABLE THERAPY BY DURATION OF ILLNESS IN PATIENTS WITH SCHIZOPHRENIA
    Brown, B.
    Turkoz, I.
    Mancevski, B.
    Mathews, M.
    Reeve-Parker, K.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2017, 51 : 161 - 161
  • [44] Evaluation of Paliperidone Palmitate Long-Acting Injectable Therapy by Duration of Illness in Patients With Schizophrenia
    Brown, Brianne
    Turkoz, Ibrahim
    Mancevski, Branislav
    Mathews, Maju
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2016, 19 : 198 - 198
  • [45] Evaluation of Paliperidone Palmitate Long-Acting Injectable Therapy by Duration of Illness in Patients With Schizophrenia
    Brown, Brianne
    Turkoz, Ibrahim
    Mancevski, Branislav
    Mathews, Maju
    BIOLOGICAL PSYCHIATRY, 2016, 79 (09) : 212S - 212S
  • [46] OVERCOMING THE CHALLENGES OF MODELLING SCHIZOPHRENIA: A UK CASE STUDY OF THE COST-EFFECTIVENESS OF OLANZAPINE LONG-ACTING INJECTION VS. RISPERIDONE LONG-ACTING INJECTION
    Carroll, S. M.
    Jemiai, N.
    Moller, J.
    Novick, D.
    VALUE IN HEALTH, 2009, 12 (07) : A350 - A350
  • [47] Cost-effectiveness analysis of paliperidone palmitate versus long-acting risperidone as maintenance treatment in schizophrenia patients in Italy
    Ravasio, Roberto
    Nicole, Giuseppe
    Vaggi, Marco
    GLOBAL & REGIONAL HEALTH TECHNOLOGY ASSESSMENT, 2015, 2 (01) : 17 - 32
  • [48] COST EFFECTIVENESS OF PALIPERIDONE PALMITATE VERSUS RISPERIDONE LONG-ACTING INJECTABLE, QUETIAPINE AND OLANZAPINE FOR THE TREATMENT OF PATIENTS WITH SCHIZOPHRENIA IN COLOMBIA
    Casallas, C.
    Ariza, J. G.
    VALUE IN HEALTH, 2013, 16 (07) : A695 - A695
  • [49] Retrospective Analysis of the Effectiveness and Tolerability of Long-Acting Paliperidone Palmitate Antipsychotic in Adolescent First-Episode Schizophrenia Patients
    Petric, Daniela
    Racki, Valentino
    Gaco, Nadija
    Kastelan, Ana
    Graovac, Mirjana
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2019, 29 (03) : 197 - 204
  • [50] Severity of Gastrointestinal Bleeding in Obese vs. Non-Obese Veterans Taking Direct Oral Anticoagulants
    Ahmad, Ammar
    Markert, Ronald
    Agrawal, Sangeeta
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S310 - S310
12345